Ecstasy is a dangerous drug

Psychological Reports

Volumn 88, Issue 3 PART 1, 2001, Pages 895-902

  Murray, John B ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; SEROTONIN;

ANIMAL; AROUSAL; BRAIN; DRUG EFFECT; HAPLORHINI; HUMAN; METABOLISM; RAT; REVIEW; RISK FACTOR;

ANIMALS; AROUSAL; BRAIN; HAPLORHINI; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RISK FACTORS; SEROTONIN;

EID: 0035375925     PISSN: 00332941     EISSN: 1558691X     Source Type: Journal    
DOI: 10.2466/pr0.2001.88.3.895     Document Type: Article

References (37)

1. BABERG, H. T., NELESEN, R. A., & DIMSDALE, J. E. (1996) Amphetamine use: return of an old scourge in a consultation psychiatry setting. American Journal of Psychiatry, 153, 789-793.
2. BARNES, D. M. (1988) New data intensify the agony over ecstasy. Science, 239, 864-868.
3. BATTAGLIA, G., YEH, S. Y., & DESOUZA, E. G. (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacology Biochemistry and Behavior, 29, 269-274.
4. BENAZZI, F., & MAZZOLI, M. (1991) Psychiatric illness associated with "ecstasy". Lancet, 338, 1520.
5. BOST, R. O. (1988) 3.4-methylenedioxymethamphetamine (MDMA) and other amphetamine derivatives. Journal of forensic Sciences, 33, 576-587.
6. COHEN, R. S. (1995) Subjective reports on the effects of the MDMA ('Ecstasy') experience in humans. Progress in Neuropsychopharmacology and Biological Psychiatry, 19, 1137-1145.
7. COHEN, R. S. (1996) Adverse symptomatology and suicide associates with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy"). Biological Psychiatry, 39, 819-820.
8. COHEN, R. S., & COCORES, J. (1997) Neuropsychiatrie manifestations following the use of 3,4-methylenedioxymethamphetamine. Progress in Neuropsychopharmacology and Biological Psychiatry, 21, 727-734.
9. CREIGHTON, F. J., BLACK, D. L., & HYDE, C. E. (1991) 'Ecstasy' psychosis and flashbacks. British Journal of Psychiatry, 159, 713-715.
10. DOWLING, G. P., MCDONOUGH, E. T., & BOST, R. O. (1987) 'Eve' and 'Ecstasy': a report of five deaths associated with the use of MDEA and MDMA. The Journal of the American Medical Association, 251, 1615-1617.
11. ELK, C. (1996) MDMA (Ecstasy): useful information for health professionals involved in drug education programs. Journal of Drug Education, 26, 349-350.
12. GOLD, L. H., HUBNER, C. B., & KOOB, G. F. (1989) A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA. Psychopharmacology, 99, 40-47.
13. GOUZOULIS-MAYFRANK, E., THELEN, B., HABERMEYER, E., KUNERT, H. J., KOVAR, K. A., LINDENBLATT, H., HERMLE, L., SPITZER, M., & SASS, H. (1999) Psychpathological, neuroendocrine and d-amphetamine in healthy volunteers. Psychopharmacology, 142, 41-50.
14. GREER, G., & STRASSMAN, R. J. (1985) Information on $Ecstasy". American Journal of Psychiatry, 142, 1391. [letter]
15. GRINSPOON, L., & BAKALAR, J. B. (1986) Can drugs be used to enhance the psychotherapeutic process? American Journal of Psychotherapy, 40, 393-404.
16. GROB, C., BRAVO, G., & WALSH, R. (1990) Second thoughts on 3.4-methylenedioxymethamphet-amine (MDMA) neurotoxicity (letter). Archives of General Psychiatry, 47, 288.
17. GROB, C. S., BRAVO, G. L., WALSH, R. N., & LIESTER, M. B. (1992) The MDMA-neurotoxicity controversy: implications for clinical research with novel psychoactive drugs. Journal of Nervous and Mental Disease, 180, 355-356.
18. HENRY, J. A., JEFFREYS, K. J., & DAWLING, S. (1992) Toxicity and deaths from 3.4-methylenedioxymethamphetamine ("ecstasy"). Lancet, 340, 384-387.
19. KOSTEN, T. R., & PRICE, L. H. (1992) Phenomenology and sequelae of 3, 4-methylenedioxymethamphetamine use. Journal of Nervous and Mental Disease, 180, 353-354.
20. LIESTER, M. B., GROB, C. S., BRAVO, G. L., & WALSH, R. N. (1992) Phenomenology and sequelae of 3, 4-methylenedioxymethamphetamine use. Journal of Nervous and Mental Disease, 180, 345-352.
21. MCCANN, U. D., & RICAURTE, G. A. (1992) MDMA ("Ecstasy") and panic disorder: induction by a single dose. Biological Psychiatry, 32, 950-953.
22. MCGUIRE, P., & FAHY, J. (1991) Chronic paranoid psychosis after misuse of MDMA ("ecstasy"). British Medical Journal, 302, 697.
23. MURRAY, J. B. (1998) Psychophysiological aspects of amphetamine-methamphetamine abuse. The Journal of Psychology, 132, 227-237.
24. NAGEL, L., McDOUGALL, D., & GRANBY, D. (1996) Students' self-reported substance abuse by grade level and gender. Journal of Drug Education, 26, 49-56.
25. PALLANTI, S., & MAZZI, D. (1992) MDMA (Ecstasy) precipitation of panic disorder. Biological Psychiatry, 32, 91-95.
26. PEROUTKA, S. J. (1987) Incidence of recreational use of 3.4-methylenedimethoxymethamphetamine (MDMA, "Ecstasy") on an undergraduate campus. New England Journal of Medicine. 317, 1542-1543.
27. PEROUTKA, S. J. (1989) 'Ecstasy': a human neurotoxin? Archives of General Psychiatry, 46, 191. [letter]
28. RANDALL, T. (1992) 'Rave' scene, ecstasy use, leap Atlantic. The Journal of the American Medical Association, 268, 1505.
29. RICAURTE, G. A., DELANNEY, L. E., IRWIN, I., & LANGSTON, J. W. (1988) Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Research, 446, 165-168.
30. RICAURTE, G. A., FORNO, L. S., WILSON, M. A., DELANNEY, L. E., IRWIN, I., MOLLIVER, M. E., & LANGSTON, J. W. (1988) (+) 3.4-methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. The Journal of the American Medical Association, 260, 51-55.
31. ROTHWELL, P. M., & GRANT, R. (1993) Cerebral venous sinus thrombosis induced by 'Ecstasy'. Journal of Neurology, Neurosurgery, and Psychiatry, 56, 1035.
32. SCHIFANO, F. (1991) Chronic atypical psychosis associated with MDMA ("ecstasy") abuse. Lancet, 338, 1335.
33. SCHMIDT, C. J. (1986) Neurotoxicity of the psychedelic amphetamine methylenedioxymethamphetamine. Journal of Pharmacology and Experimental Therapeutics, 240, 1-7.
34. SCHMIDT, C. J., WU, L., & LOVENBERG, W. (1986) Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue. European Journal of Pharmacology, 124, 175-178.
35. SHULGUN, A. T. (1986) The background and chemistry of MDMA. Journal of Psychoactive Drugs, 18, 291-304.
36. SOLOWIJ, N., HALL, W., & LEE, N. (1992) Recreational MDMA in Sydney: a profile of "Ecstasy" users and their experience with the drug. British Journal of Addiction, 87, 1161-1178.
37. WHITAKER-AZMITIA, P. M., & ARONSON, T. A. (1989) "Ecstasy" (MDMA)-induced panic. American Journal of Psychiatry, 146, 119. [letter]